Correction: ¹⁸F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials

Clin Cancer Res. 2019 Feb 15;25(4):1435. doi: 10.1158/1078-0432.CCR-18-4266.

Authors

Yingbing Wang, Karen L Ayres, Debra A Goldman, Maura N Dickler, Aditya Bardia, Ingrid A Mayer, Eric Winer, Jill Fredrickson, Carlos L Arteaga, José Baselga, Henry C Manning, Umar Mahmood, Gary A Ulaner

PMID: 30770494
DOI: 10.1158/1078-0432.CCR-18-4266

No abstract available

Publication types

Published Erratum